The Challenge of Opioid Therapy: Proper Patient Selection & Careful Patient Management
Release Date: November 2008
Expiration Date: November 30, 2009
Sponsored by the Dannemiller Memorial Educational Foundation
This educational activity is made possible by an educational grant from Purdue Pharma, L.P.
FACULTY:
Bill H. McCarberg, MD, FABPM
Chronic Pain Management Program,
Kaiser Permanente San Diego
San Diego, California
Target Audience/Program Description
The purpose of this educational activity is to provide information to Pain Specialist Physicians, Family Practitioners, and Pharmacists in prescribing opioids for their chronic pain patients for accurate diagnosis and successful management.
Statement of Need
The purpose of this educational activity is to provide information to pain specialists in prescribing opioids for their chronic pain patients for accurate diagnosis and successful management.
LEARNING OBJECTIVES:
- Identify patient screening tools and methodologies necessary for the proper identification of patients for opioid therapy.
- Apply these tools and methodologies to properly screen patients with challenging medical issues.
- Discuss the most recent evidence-based clinical trials regarding the effective use of opioids in the management of moderate to severe chronic pain.
- Recognize drug seeking behavior and methods available to physicians to prevent opioid misuse, abuse and diversion.
- Apply appropriate laws and ethical standards relating to prescribing and dispensing of opioids for the management of moderate to severe chronic pain.
Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME). The Dannemiller Memorial Educational Foundation is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Dannemiller Memorial Educational Foundation designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity will provide 1 hour ethics and/or professional responsibility.
Pharmacy
 
Credit Designation
Purdue University School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Program Universal Program Number (UPN): 018-999-08-114-H04-P, 1.0 contact hours (0.10 CEU) Release Date: November 2008, Expiration Date: November 30, 2010.
Nurse Practitioner
This program is approved for 1.0 contact hour(s) of continuing education by the American Academy of Nurse Practitioners. Program ID 0811538.
Method of Participation:
This activity should take approximately 1 hour to complete. The participant should, in order, read the objectives and other introductory CME information review the slides, complete the registration form, post-test, and evaluation form. The evaluation form provides each participant the opportunity to comment on the extent to which educational objectives were met, the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias, and his or her views on future educational needs. To access the registration form and post-test, click on the “CME Post-Test” button on the final slide in the presentation. To receive credit for this activity, follow the instructions provided on the post-test. This credit is valid through November 30, 2009. No credit will be given after this date. There is no fee associated with this CME activity.
In the event you are unable to print the certificate, please submit the post-test and then editor@dannemiller.com; a certificate will be mailed within 2 weeks.
Disclosure
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), the Dannemiller Memorial Educational Foundation requires that any person who is in a position to control the content of a CME activity must disclose all relevant financial relationships they have with a commercial interest. Accordingly:
Dr. McCarberg serves on the Speakers Bureau for Endo Pharmaceuticals, Eli Lilly and Company, Pfizer, Inc., Merck & Co. Inc., Alpharma Inc., King Pharmaceuticals, Inc., Cephalon, Inc, and Pricara.
The Dannemiller Memorial Educational Foundation staff that was involved in the development of this activity has no financial relationships with any commercial interest that are relevant to this activity.
To resolve identified conflicts of interest, the educational content was fully peer-reviewed by a physician member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.
Disclosure of Unlabeled or Investigational Drugs
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should critically appraise the information presented and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Disclaimers
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of The Dannemiller Memorial Educational Foundation and Purdue Pharma, LP. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.
» Click Here To Begin
|